Cramer's Top Homebu...
Health Care: Drugs
Venaxis Inc (APPY: NASDAQ)
$1.30 -0.06 | -4.41%
05/24/13 - 04:00 PM ET
Company Income Statement
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Sales | 62.13K | 281.60K | 370.23K | 504.82K |
| Cost of Sales | 592.00 | 16.34K | 358.09K | 31.13K |
| Gross Operating Profit | 61.54K | 265.25K | 12.14K | 473.69K |
| Selling, General, and Administrative Expenses | 5.18M | 5.58M | 7.51M | 6.63M |
| Research & Development | 3.84M | 5.67M | 6.02M | 8.71M |
| Operating Income before D & A (EBITDA) | -8.96M | -10.98M | -13.52M | -14.87M |
| Depreciation & Amortization | 409.66K | 428.34K | 423.77K | 174.26K |
| Interest Income | 0.00 | 16.42K | 61.70K | 189.43K |
| Other Income - Net | -1.92K | 942.90K | 313.02K | -461.68K |
| Special Income / Charges | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Income Before Interest Expenses (EBIT) | -9.37M | -10.45M | -13.57M | -15.32M |
| Interest Expense | 248.63K | 196.93K | 194.48K | 200.14K |
| Pre-Tax Income | -9.62M | -10.64M | -13.76M | -15.52M |
| Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing Operations | -9.21M | -10.21M | -13.34M | -15.52M |
| Net Income From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Total Operations | -9.21M | -10.21M | -13.34M | -15.52M |
| Extraordinary Income/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Cum. Effect of Acct. Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Tax Loss Carryforward | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Net Income | -9.21M | -10.21M | -13.34M | -15.52M |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-9.21M | -10.21M | -13.34M | -15.52M |
| Preferred Dividends | ||||
|---|---|---|---|---|
| Net Income Available To Common | -9.21M | -10.21M | -13.34M | -15.52M |
| Basic EPS from Continuing Ops. | -1.84 | -7.62 | -10.20 | -14.10 |
| Basic EPS from Discontinued Ops. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Total Operations | -1.84 | -7.62 | -10.20 | -14.10 |
| Basic EPS from Extraordinary Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Tax Loss Carryf'd. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Other Gains (Losses) | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS, Total | -1.84 | -7.62 | -10.20 | -14.10 |
| Basic Normalized Net Income/Share | -1.84 | -7.62 | -10.20 | -14.10 |
| EPS fr Continuing Ops. | -1.84 | -7.62 | -10.20 | -14.10 |
| EPS fr Discontinued Ops | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Total Ops. | -1.84 | -7.62 | -10.20 | -14.10 |
| EPS fr Extraord. Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Tax Loss Carfd. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Other Gains (L) | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS, Total | -1.84 | -7.62 | -10.20 | -14.10 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-1.84 | -7.62 | -10.20 | -14.10 |
| Dividends Paid per Share | 0.00 | 0.00 | 0.00 | 0.00 |
Portfolios with APPY
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
- UserSUPRATRADE-2709091838
- UserBrahmsian's Debt/Equity Por...
- UserBrahmsian's Financially Sou...
- Userdan vosika Portfolio 1
- Usergame on
- Userdreamerl3oi Portfolio 1
- Useremannn Portfolio 1
Latest APPY Headlines from TheStreet
- 5 Biotech Stocks Under $10 Moving Higher 01.30.13 | 08:01 am
- 5 Breakout Stocks: Must-See Charts 12.21.12 | 05:12 pm
- 5 Stocks Under $10 Set to Soar Higher 09.27.12 | 01:09 pm
- 4 Biotech Stocks Under $10 Making Big Moves 09.11.12 | 02:09 pm
- Biotech Sector Weekly Rewind 11.13.10 | 07:11 am
- Vantage Drilling, First M&F: Volume Movers 07.20.10 | 07:07 am
- AspenBio Finds Fault Afar for Failure 07.20.10 | 06:07 am
- Biotech Stock Mailbag: Spectrum Pharma 06.18.10 | 07:06 am
- Hellenic Telecom, AspenBio Pharma: Midday Volume Plays 06.07.10 | 12:06 pm
- Stock Offerings: Navios Maritime 04.30.10 | 11:04 am
Press Releases for APPY
- Venaxis Announces Pricing Of Offering Of Common Stock And Warrants - PR Newswire 05.23.13 | 07:05 pm
- Venaxis Appoints SomaLogic CMO And Former Pfizer Executive Stephen A. Williams, M.D., Ph.D., To Board Of Directors - PR Newswire 04.18.13 | 04:04 pm
- Venaxis Advances Pivotal U.S. Study And Accelerates European Market Development For APPY1 Blood-based Appendicitis Test - PR Newswire 03.26.13 | 04:03 pm
- Venaxis To Provide Fourth Quarter 2012 Business Update - PR Newswire 03.19.13 | 07:03 am
- Venaxis Secures Additional European Commercial Development Agreements For APPY1 - PR Newswire 03.18.13 | 07:03 am
- Venaxis To Present At 25th Annual ROTH Conference - PR Newswire 03.11.13 | 04:03 pm
- Venaxis Executes First Commercial Development Agreement And Receives Purchase Order From EMELCA Bioscience For Initial EU Launch - PR Newswire 02.07.13 | 07:02 am
- Venaxis Initiates Patient Enrollment For APPY1 Pivotal Study - PR Newswire 01.15.13 | 07:01 am
- Venaxis Obtains CE Mark For APPY1 Appendicitis Test - PR Newswire 01.07.13 | 04:01 pm
- Venaxis Files For CE Mark And Prepares For European Commercialization - PR Newswire 12.21.12 | 07:12 am
Partner Headlines for APPY
- Weekly CFO Buys Highlight: CPRX, APPY, MEI, MNKD - GuruFocus 07.09.12 | 01:07 pm
- Weekly Market Wrap: Markets SHAKE, Microsoft's NEW Product, Bank Ratings SLASHED - Wall St. Cheat Sheet 06.23.12 | 09:06 am
- P&G SHAVES Profit Outlook and 4 Hot Stocks to Watch - Wall St. Cheat Sheet 06.20.12 | 12:06 pm
- Market Wrap: Oil SPILLS Lower, Microsoft RALLIES, Operation TWIST - Wall St. Cheat Sheet 06.20.12 | 10:06 am
- Morning Market Losers - Benzinga 06.20.12 | 09:06 am
- Ultimate Market Recap: Iffy Adobe Guidance, Jabil Jumps 7% - Wall St. Cheat Sheet 06.20.12 | 08:06 am
- Zacks #1 Rank Additions for Tuesday - Tale of the Tape - Zacks 06.19.12 | 09:06 am
- Zacks #1 Rank Additions for Tuesday - Tale of the Tape - Zacks 06.05.12 | 09:06 am
- Morning Market Losers - Benzinga 12.19.11 | 09:12 am
- AspenBio Pharma Reports AppyScore(TM) ELISA-Based Pivotal Trial Results and Outlines Plans for AppyScore Cassette-Based Test - Benzinga 07.19.10 | 04:07 pm
